Related Experiment Video
Updated: Jun 20, 2026

Combining Double Fluorescence In Situ Hybridization with Immunolabelling for Detection of the Expression of Three Genes in Mouse Brain Sections
Published on: March 26, 2016
[Long term clinical course of Canavan disease--a rare Japanese case]
Koichi Mizuguchi1, Hideki Hoshino, Hiroshi Hamaguchi
1Division of Neurology, National Center for Child Health and Development, Tokyo. mizu0609@s07.itscom.net
Abstract:
Canavan disease (CD), which is a rare disease in Japan, is an autosomal-recessive neurodegenerative disorder caused by mutations in aspartoacylase, an enzyme that deacetylates N-acetylaspartate to generate free acetate in the brain. CD affected children usually die by the age of 10 years. Here we report a long term clinical course of a 21-year-old Japanese woman who was diagnosed as CD at the age 4. This patient is the only reported case of CD in Japan that has been biochemically confirmed. Although this patient is currently bed-ridden with spastic quadriplegia and severe mental retardation, her general condition is quite stable. This patient showed a milder clinical course compared to the majority of CD patients. Because this is the only reported case of CD in Japan, we hypothesize that there might be an ethnic phenotypic polymorphism in CD.
Related Concept Videos
Huntington Disease l: Introduction
Lysosomal Hydrolases
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Kidney Disease II: Clinical Manifestations
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction